A patient taking
fusidic acid with saquinavir and
ritonavir developed elevated
fusidic acid levels with
toxicity, and elevated saquinavir and
ritonavir levels (roughly 4-fold increases).
The
clinical significance of this case is unclear. It has been suggested that concurrent use should be avoided.